92 related articles for article (PubMed ID: 1635294)
1. Characterization of T-cell subsets, soluble interleukin-2 receptors and interleukin-6 in Vogt-Koyanagi-Harada disease.
Kogiso M; Tanouchi Y; Miki S; Mimura Y
Jpn J Ophthalmol; 1992; 36(1):37-43. PubMed ID: 1635294
[TBL] [Abstract][Full Text] [Related]
2. Dominance of activated T cells and interleukin-6 in aqueous humor in Vogt-Koyanagi-Harada disease.
Norose K; Yano A; Wang XC; Tokushima T; Umihira J; Seki A; Nohara M; Segawa K
Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):33-9. PubMed ID: 8300361
[TBL] [Abstract][Full Text] [Related]
3. Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome.
Chen L; Yang P; Zhou H; He H; Ren X; Chi W; Wang L; Kijlstra A
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3475-82. PubMed ID: 18421089
[TBL] [Abstract][Full Text] [Related]
4. Immunologic analysis of cerebrospinal fluid lymphocytes in Vogt-Koyanagi-Harada disease.
Norose K; Yano A; Aosai F; Segawa K
Invest Ophthalmol Vis Sci; 1990 Jul; 31(7):1210-6. PubMed ID: 2142146
[TBL] [Abstract][Full Text] [Related]
5. [Peripheral lymphocyte subsets in patients with Vogt-Koyanagi-Harada syndrome (VKH)].
Liu T; Sun SM
Zhonghua Yan Ke Za Zhi; 1993 May; 29(3):138-40. PubMed ID: 8223036
[TBL] [Abstract][Full Text] [Related]
6. T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis.
Damico FM; Cunha-Neto E; Goldberg AC; Iwai LK; Marin ML; Hammer J; Kalil J; Yamamoto JH
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2465-71. PubMed ID: 15980237
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric analysis of T cell subsets in paired samples of cerebrospinal fluid and peripheral blood from patients with neurological and psychiatric disorders.
Maxeiner HG; Rojewski MT; Schmitt A; Tumani H; Bechter K; Schmitt M
Brain Behav Immun; 2009 Jan; 23(1):134-42. PubMed ID: 18771722
[TBL] [Abstract][Full Text] [Related]
8. Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease.
Norose K; Yano A
Br J Ophthalmol; 1996 Nov; 80(11):1002-8. PubMed ID: 8976730
[TBL] [Abstract][Full Text] [Related]
9. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease.
Chi W; Yang P; Li B; Wu C; Jin H; Zhu X; Chen L; Zhou H; Huang X; Kijlstra A
J Allergy Clin Immunol; 2007 May; 119(5):1218-24. PubMed ID: 17335887
[TBL] [Abstract][Full Text] [Related]
10. A case of vogt-koyanagi-harada disease associated with malignant lymphoma.
Hashida N; Kanayama S; Kawasaki A; Ogawa K
Jpn J Ophthalmol; 2005; 49(3):253-6. PubMed ID: 15944834
[TBL] [Abstract][Full Text] [Related]
11. Soluble interleukin 2 receptor levels in serum and its relationship to T cell abnormality and clinical manifestations of the disease in patients with systemic lupus erythematosus.
Raziuddin S; al-Janadi MA; al-Wabel AA
J Rheumatol; 1991 Jun; 18(6):831-6. PubMed ID: 1680190
[TBL] [Abstract][Full Text] [Related]
12. Circulating activated T lymphocytes in autoeczematization.
Kasteler JS; Petersen MJ; Vance JE; Zone JJ
Arch Dermatol; 1992 Jun; 128(6):795-8. PubMed ID: 1599265
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum levels of soluble interleukin-2 receptors in HIV infection: no correlation with activated T cells.
Lang JM; Coumaros G; Levy S; Falkenrodt A; Steckmeyer M; Partisani M; Aleksijevic A; Lehr L; Koehl C
Nouv Rev Fr Hematol (1978); 1989; 31(1):9-11. PubMed ID: 2783774
[TBL] [Abstract][Full Text] [Related]
14. Expression and release of IL-2 receptor and production of IL-2 by activated T lymphocyte subsets.
Shahabuddin S
J Clin Lab Immunol; 1991 Sep; 36(1):27-32. PubMed ID: 1668858
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum IL-23 correlates with intraocular inflammation after cataract surgery in patients with Vogt-Koyanagi-Harada disease.
Jiang S; Liu X; Luo L; Qu B; Huang X; Xu L; Lin Y; Ye S; Liu Y
Br J Ophthalmol; 2010 Aug; 94(8):1078-82. PubMed ID: 19910285
[TBL] [Abstract][Full Text] [Related]
16. Identification of autoreactive T cells in Vogt-Koyanagi-Harada disease.
Gocho K; Kondo I; Yamaki K
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2004-9. PubMed ID: 11481264
[TBL] [Abstract][Full Text] [Related]
17. Chemokine profile in the cerebrospinal fluid and serum of Vogt-Koyanagi-Harada disease.
Miyazawa I; Abe T; Narikawa K; Feng J; Misu T; Nakashima I; Fujimori J; Tamai M; Fujihara K; Itoyama Y
J Neuroimmunol; 2005 Jan; 158(1-2):240-4. PubMed ID: 15589059
[TBL] [Abstract][Full Text] [Related]
18. Expression of Fas antigen on helper T lymphocytes in Vogt-Koyanagi-Harada disease.
Ohta K; Yoshimura N
Graefes Arch Clin Exp Ophthalmol; 1998 Jun; 236(6):434-9. PubMed ID: 9646088
[TBL] [Abstract][Full Text] [Related]
19. [Activated T cells in the peripheral blood of patients with subacute myelo-optico-neuropathy (SMON)].
Matsuda M; Miyagi K; Yanagisawa N; Tsukada N
Arerugi; 1994 Mar; 43(3):515-20. PubMed ID: 8198461
[TBL] [Abstract][Full Text] [Related]
20. Increased IL-7 expression in Vogt-Koyanagi-Harada disease.
Yang Y; Xiao X; Li F; Du L; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):1012-7. PubMed ID: 22247488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
